The University of California Berkeley and UC San Francisco have partnered with the Janssen Pharmaceuticals unit of Johnson & Johnson to establish a fellowship program for data science-driven health innovation.
Program research will center on finding innovative, data-driven solutions to currently unmet patient needs. Potential projects marrying large biomedical datasets and actionable clinical solutions could include, for example, new methods to recruit participants for clinical trials or artificial intelligence-powered apps informing patients about their treatment plans and early warning signs of disease.
The program will be jointly run by both universities, with participants carrying out research at the Berkeley Institute for Data Science and the Bakar Computational Health Sciences Institute in San Francisco. Researchers will have access to Janssen's product and platform teams, as well as mentorship from UC experts in computer science, data, engineering, statistics, tech innovation and clinical experience.
More articles about health IT:
Don’t overlook cybersecurity training — Why Lake Chelan Community Hospital CIO created his own cyber program
5 ways to spot potential EHR fraud
AI-guided robotic device replaces endoscopy in diagnosing colon cancer